Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Clinical Cancer Research

• Publication date

  2006-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-05-1383PMID 16489062
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clustering of minimal deleted regions reveals distinct genetic pathways of human hepatocellular carcinoma.

  2004cited by this paper
• Function analysis of estrogenically regulated protein tyrosine phosphatase gamma (PTPgamma) in human breast cancer cell line MCF-7.

  2004cited by this paper
• Allelic loss of chromosome 4q21 approximately 23 associates with hepatitis B virus-related hepatocarcinogenesis and elevated alpha-fetoprotein.

  2004cited by this paper
• Mutational Analysis of the Tyrosine Phosphatome in Colorectal Cancers

  2004cited by this paper
• Function analysis of estrogenically regulated protein tyrosine phosphatase γ (PTPγ) in human breast cancer cell line MCF-7

  2004cited by this paper
• Allelic loss of chromosome 4q21 ≈︁ 23 associates with hepatitis B Virus—related hepatocarcinogenesis and elevated alpha‐fetoprotein

  2004cited by this paper
• Gene silencing in cancer in association with promoter hypermethylation.

  2003cited by this paper
• Structure determination and ligand interactions of the PDZ2b domain of PTP-Bas (hPTP1E): splicing-induced modulation of ligand specificity.

  2003cited by this paper
• FAP-1 Association with Fas (Apo-1) Inhibits Fas Expression on the Cell Surface

  2003cited by this paper
• The protein tyrosine phosphatase PTP-BL associates with the midbody and is involved in the regulation of cytokinesis.

  2003cited by this paper
• The protein tyrosine phosphatase PTP-Basophil/Basophil-like. Interacting proteins and molecular functions.

  2003cited by this paper
• Mechanisms of viral hepatitis induced liver injury.

  2003cited by this paper
• Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia

  2003cited by this paper
• Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma.

  2003cited by this paper
• Molecular pathogenesis of human hepatocellular carcinoma

  2002cited by this paper
• Specific association between alcohol intake, high grade of differentiation and 4q34-q35 deletions in hepatocellular carcinomas identified by high resolution allelotyping

  2002cited by this paper
• Molecular Genetic Alterations in Primary Hepatocellular Neoplasms

  2002cited by this paper
• Protein-tyrosine Phosphatase PTPL1/FAP-1 Triggers Apoptosis in Human Breast Cancer Cells*

  2002cited by this paper
• EphrinB phosphorylation and reverse signaling: regulation by Src kinases and PTP-BL phosphatase.

  2002cited by this paper
• Head-to-head juxtaposition of Fas-associated phosphatase-1 (FAP-1) and c-Jun NH2-terminal kinase 3 (JNK3) genes: genomic structure and seven polymorphisms of the FAP-1 gene

  2002cited by this paper
• PROTEIN TYROSINE PHOSPHATASE PTPL 1 / FAP-1 TRIGGERS APOPTOSIS IN HUMAN BREAST CANCER CELLS

  2002cited by this paper
• Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan.

  2002cited by this paper
• The protein kinase C‐related kinase PRK2 interacts with the protein tyrosine phosphatase PTP‐BL via a novel PDZ domain binding motif

  2001cited by this paper
• Expression and potential role of Fas-associated phosphatase-1 in ovarian cancer.

  2001cited by this paper
• Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma.

  2001cited by this paper
• Expression of Fas and Fas-related molecules in human hepatocellular carcinoma.

  2001cited by this paper
• Activation of c-Src gene product in hepatocellular carcinoma is highly correlated with the indices of early stage phenotype.

  2001cited by this paper
• Identification of Two Fas-Associated Phosphatase-1 (FAP-1) Promoters in Human Cancer Cells

  2001cited by this paper
• Molecular classification of human carcinomas by use of gene expression signatures.

  2001cited by this paper
• The zyxin-related protein TRIP6 interacts with PDZ motifs in the adaptor protein RIL and the protein tyrosine phosphatase PTP-BL.

  2000cited by this paper
• The Adenomatous Polyposis Coli-protein (APC) interacts with the protein tyrosine phosphatase PTP-BL via an alternatively spliced PDZ domain

  2000cited by this paper
• Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives.

  2000cited by this paper
• Identification of a 1-cM Region of Common Deletion on 4q35 Associated With Progression of Hepatocellular Carcinoma

  2000cited by this paper
• Functional interaction of Fas‐associated phosphatase‐1 (FAP‐1) with p75NTR and their effect on NF‐κB activation

  1999cited by this paper
• ZRP-1, a Zyxin-related Protein, Interacts with the Second PDZ Domain of the Cytosolic Protein Tyrosine Phosphatase hPTP1E*

  1999cited by this paper
• Association of protein-tyrosine phosphatase PTP-BAS with the transcription-factor-inhibitory protein IkappaBalpha through interaction between the PDZ1 domain and ankyrin repeats.

  1999cited by this paper
• Hepatitis B Virus Infection and Hepatocellular Carcinoma: Molecular Genetics and Clinical Perspectives

  1999cited by this paper
• Identification of a 1‐cM region of common deletion on 4q35 associated with progression of hepatocellular carcinoma

  1999cited by this paper
• Deletion mapping of chromosome 4q in hepatocellular carcinoma

  1998cited by this paper
• pp60c‐src Activation in hepatocellular carcinoma of humans and LEC rats

  1998cited by this paper
• Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.

  1998cited by this paper
• PDZ motifs in PTP-BL and RIL bind to internal protein segments in the LIM domain protein RIL.

  1998cited by this paper
• The role of tyrosine phosphorylation in cell growth and disease.

  1998cited by this paper
• PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer

  1997cited by this paper
• Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype.

  1997cited by this paper
• Comprehensive allelotyping of human hepatocellular carcinoma

  1997cited by this paper
• Protein tyrosine phosphatases in signal transduction.

  1997cited by this paper
• A sensitive, quick and semi-quantitative LacZ assay for the two-hybrid system.

  1996cited by this paper
• Allelic loss on chromosomes 4q and 16q in hepatocellular carcinoma: association with elevated alpha-fetoprotein production.

  1996cited by this paper
• Molecular cloning of a mouse epithelial protein‐tyrosine phosphatase with similarities to submembranous proteins

  1995cited by this paper
• FAP-1: a protein tyrosine phosphatase that associates with Fas.

  1995cited by this paper
• Cloning and characterization of PTPL1, a protein tyrosine phosphatase with similarities to cytoskeletal-associated proteins.

  1994cited by this paper
• Molecular cloning of a novel protein‐tyrosine phosphatase containing a membrane‐binding domain and GLGF repeats

  1994cited by this paper
• Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas.

  1994cited by this paper
• A novel protein-tyrosine phosphatase with homology to both the cytoskeletal proteins of the band 4.1 family and junction-associated guanylate kinases.

  1994cited by this paper
• Cellular differentiation, cytidine analogs and DNA methylation.

  1980cited by this paper

• Arsenic disulfide promoted the demethylation of PTPL1 in diffuse large B cell lymphoma cells

  2024cites this paper
• Hereditable variants of classical protein tyrosine phosphatase genes: Will they prove innocent or guilty?

  2023cites this paper
• miR-200b, ZEB2 and PTPN13 Are Downregulated in Colorectal Carcinoma with Serosal Invasion

  2022cites this paper
• Protein tyrosine phosphatase PTPL1 suppresses lung cancer through Src/ERK/YAP1 signaling

  2022cites this paper
• PTPL1 suppresses lung cancer cell migration via inhibiting TGF-β1-induced activation of p38 MAPK and Smad 2/3 pathways and EMT

  2021cites this paper
• Cancer-derived IgG involved in cisplatin resistance through PTP-BAS/Src/PDK1/AKT signaling pathway.

  2020cites this paper
• Protein tyrosine phosphatase L1 represses endothelial-mesenchymal transition by inhibiting IL-1β/NF-κB/Snail signaling

  2020cites this paper
• Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression

  2020cites this paper
• Oncogenic Tyrosine Phosphatases: Novel Therapeutic Targets for Melanoma Treatment

  2020cites this paper
• PTPN13 induces cell junction stabilization and inhibits mammary tumor invasiveness

  2020cites this paper
• PTPN13 acts as a tumor suppressor in clear cell renal cell carcinoma by inactivating Akt signaling.

  2020cites this paper
• Dual Role of the PTPN13 Tyrosine Phosphatase in Cancer

  2020influential citation
• Protein tyrosine phosphatases: promising targets in pancreatic ductal adenocarcinoma

  2019cites this paper
• Identification of key genes and pathways in Ewing's sarcoma using bioinformatics analysis.

  2018cites this paper
• The impact of phosphatases on proliferative and survival signaling in cancer

  2018cites this paper
• The Roles of Protein Tyrosine Phosphatases in Hepatocellular Carcinoma

  2018cites this paper
• Whole-Exome Sequencing-Based Mutational Profiling of Hepatitis B Virus-Related Early-Stage Hepatocellular Carcinoma

  2017cites this paper
• High PTPN13 expression in high grade serous ovarian carcinoma is associated with a better patient outcome

  2017cites this paper
• Tumor suppressive protein phosphatases in human cancer: Emerging targets for therapeutic intervention and tumor stratification.

  2017influential citation
• Protein Tyrosine Phosphatases in Cancer

  2016cites this paper
• Régulation de l'agressivité tumorale mammaire par la protéine tyrosine phosphatase PTPL1/PTPN13

  2016cites this paper
• Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family *

  2016influential citation
• Tumour-suppressive role of PTPN13 in hepatocellular carcinoma and its clinical significance

  2016cites this paper
• Non-transmembrane PTPs in Cancer

  2016cites this paper
• Lower Fas-associated phosphatase-1 expression predicted poor outcome in acute myeloid leukemia patients

  2016cites this paper
• 5-Azacitidine induces demethylation of PTPL1 and inhibits growth in non-Hodgkin lymphoma

  2015cites this paper
• Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer

  2015cites this paper
• Protein tyrosine phosphatases as potential therapeutic targets

  2014cites this paper
• SND1 mediated downregulation of PTPN23 in HCC

  2014cites this paper
• The role of PTPN13 in invasion and metastasis of lung squamous cell carcinoma.

  2013cites this paper
• Therapeutics , Targets , and Chemical Biology TargetingERBBReceptorsShifts Their Partners andTriggers Persistent ERK Signaling through a Novel ERBB / EFNB 1 Complex

  2013cites this paper
• Targeting ERBB receptors shifts their partners and triggers persistent ERK signaling through a novel ERBB/EFNB1 complex.

  2013cites this paper
• Autophagy variation within a cell population determines cell fate via selective degradation of Fap-1

  2013cites this paper
• Protein tyrosine phosphatase variants in human hereditary disorders and disease susceptibilities.

  2013cites this paper
• The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis

  2013cites this paper
• The role of PTPRK and PTPRM in prostate and breast cancer

  2013cites this paper
• Decoding the disease-associated proteins encoded in the human chromosome 4.

  2013cites this paper
• Impact of oncogenic protein tyrosine phosphatases in cancer.

  2012cites this paper
• An expression signature of phenotypic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis

  2012cites this paper
• ErbB2, EphrinB1, Src Kinase and PTPN13 Signaling Complex Regulates MAP Kinase Signaling in Human Cancers

  2012cites this paper
• The nonreceptor-type tyrosine phosphatase PTPN13 is a tumor suppressor gene in non-small cell lung cancer.

  2012cites this paper
• PDZ domains: the building blocks regulating tumorigenesis.

  2011cites this paper
• PTPN13 (Protein tyrosine phosphatase, non- receptor type 13)

  2011cites this paper
• PTPs: Redox controlled regulators of cell signaling and transformation

  2011cites this paper
• PTPN13/PTPL1: an important regulator of tumor aggressiveness.

  2011cites this paper
• A Meta-Analysis of Array-CGH Studies Implicates Antiviral Immunity Pathways in the Development of Hepatocellular Carcinoma

  2011cites this paper
• Inside the human cancer tyrosine phosphatome

  2010cites this paper
• THE PUTATIVE TUMOUR SUPPRESSOR GENE PTPN13/PTPL1 INDUCES APOPTOSIS THROUGH IRS-1 DEPHOSPHORYLATION.

  2010cites this paper
• Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancers

  2010cites this paper
• Concurrent analysis of copy number variation and gene expression: Application in paired non-smoking female lung cancer patients

  2010cites this paper
• PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase.

  2010cites this paper
• Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects.

  2010cites this paper
• Expression of the putative tumor suppressor gene PTPN13/PTPL1 is an independent prognostic marker for overall survival in breast cancer

  2009cites this paper
• Impaired PTPN13 phosphatase activity in spontaneous or HPV-induced squamous cell carcinomas potentiates oncogene signaling via the MAP kinase pathway

  2009cites this paper
• Reversion-induced LIM interaction with Src reveals a novel Src inactivation cycle

  2009cites this paper
• Genetic polymorphisms in the PTPN13 gene and risk of squamous cell carcinoma of head and neck.

  2009cites this paper
• PTPL1: a large phosphatase with a split personality

  2008cites this paper
• Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling

  2008influential citation
• The putative tumor suppressor gene PTPN13/PTPL1 induces apoptosis through insulin receptor substrate-1 dephosphorylation.

  2007cites this paper
• Protein tyrosine phosphatases: from genes, to function, to disease

  2006cites this paper
• Cytogenetic and molecular genetic alterations on chromosome 4 q in human hepatocellular carcinoma

  year unknowncites this paper